Stock Analysis of Telesis Bio Inc. (TBIO) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code TBIO
Close 4.50
Change 0.150 / 3.45 %
Volume 20550.00
Vol Change 4088.00 / 24.83 %
IndustryMedical Devices
SectorHealthcare
AIO Strength Index
Technical StrengthBearish
Growth Index Good Growth
Value Index Low Value Stock
Profitability Index Poor Profitability Stock
Stability Index Very Low Stability Stock


Fundamental View of Telesis Bio Inc.


Highs/Lows of Telesis Bio Inc.
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week5.12 12.11 % 1.54 % 4.693.960115-May-2414-May-24
Two Week5.94 24.24 % 3.42 % 7.28823.960108-May-2414-May-24
One Month6.84 34.21 % 5.60 % 8.35383.960118-Apr-2414-May-24
Three Month5.6862 20.86 % 5.95 % 15.4623.960123-Feb-2414-May-24
Six Months6.66 32.43 % 17.48 % 15.4623.960123-Feb-2414-May-24
One year36.54 87.68 % 27.52 % 43.023.960122-May-2314-May-24
Two year79.92 94.37 % 29.70 % 59.763.960131-Mar-2314-May-24


Technical View of Telesis Bio Inc.






Charts of Telesis Bio Inc.


Returns of Telesis Bio Inc. with Peers
Period / StockTBIONXLNUROVVOSSQZ
1 Week-12.11%2.34%-9.33%7.76%-13.85%
1 Mth-34.21%-0.758%13.27%-13.91%-55.61%
3 Mth-20.86%285.18%18.58%-56.38%-55.29%
6mth-32.43%330.92%0.290%-43.32%-66.41%
1 Year-87.68%70.11%-48.42%-76.82%-91.79%
2 Year-94.37%--85.05%-94.01%-98.29%
5 Years---92.15%--
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of Telesis Bio Inc. with Peers
Ratio / StockTBIONXLNUROVVOSSQZ
PE-0.166-1.96-0.681-128.36-0.107
P/B0.1972.770.266990.270.136
ROA-51.13-112.28-36.37-122.79-62.81
ROE-30903.01-141.20-39.07-771.50-126.79
Debt To Equity0.2400.00140.00741.150.115
Revenue30001.00 K
9.35 %
128636
90.26 %
5901.43 K
28.52 %
14503.00 K
9.49 %
21478.00 K
20.74 %
Net Income-38169.00 K
21.25 %
-4597.72 K
170.80 %
-6529.49 K
47.84 %
-15413.00 K
35.36 %
-79464.00 K
15.60 %


Technicals of Telesis Bio Inc. with Peers
Technical / StockTBIONXLNUROVVOSSQZ-
ADX11.1515.5527.6533.4132.46
CMF0.076-0.03280.299-0.0090-0.154
MFI25.0672.1323.4738.3281.92
RSI35.2246.3843.5040.3632.17
MACD Abv SignalFalseFalseFalseTrueFalse
Price Above 50 MAFalseFalseFalseFalseFalse-
Price Above 200 MAFalseTrueFalseFalseFalse-


About : Telesis Bio Inc.


Address : 10431 Wateridge Circle, San Diego, CA, United States, 92121-2993
Tel : 858 228 4115
URL : https://telesisbio.com
Code : TBIO, Exchange : NASDAQ, Country : USA
Fiscal Year End : December
IPO date : 18_Jun_2021
Employee Count : 137

Telesis Bio, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. The company offers BioXp 3250 system and BioXp 9600 system that empower researchers to go from a digital DNA sequence to endpoint-ready synthetic deoxyribonucleic acid (DNA) and messenger ribonucleic acid (mRNA) with onboard next generation sequencing (NGS) library preparation; BioXp portal, an online portal that offers an intuitive guided workflow and design tools for building new DNA sequences and assembling them into vectors of choice, as well as mRNA constructs; and BioXp De Novo kits, which contains building blocks and reagents, including proprietary Gibson assembly branded reagents for specific synthetic biology workflow applications. It also provides BioXp Select kits that offers to use non-telesis bio DNA while using the BioXp system to perform synthetic biology workflow applications, such as cloning, mRNA generation from plasmid, and cell free amplification; BioXp Next Generation Sequencing kits, which contains reagents to go from DNA or RNA to a sequencer-ready library; Benchtop reagents that contains the reagents to proceed specific synthetic biology workflow on the benchtop using products generated on the BioXp system; and custom Gibson short oligo ligation assembly enzymatic DNA synthesis solutions, which is designed to construct synthetic DNA, RNA, and proteins for development of mRNA-based vaccines, diagnostics, therapeutics, and personalized medicines. The company serves its products to government institutions, contract research organizations, and synthetic biology companies. The company was formerly known as Codex DNA, Inc. and changed its name to Telesis Bio Inc. in November 2022. Telesis Bio, Inc. was incorporated in 2011 and is headquartered in San Diego, California.


Note : All Data Generated at the End of Trading Hours (EOD Data)